Core Scientific CFO receives 120,074-share RSU grant

Nygaard James P Jr reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Nygaard James P Jr reported acquisition or exercise transactions in this Form 4 filing.

Core Scientific, Inc. executive vice president and chief financial officer James P. Nygaard Jr. reported receiving a grant of 120,074 shares of Common Stock in the form of restricted stock units as equity compensation.

According to the filing, one-third of these RSUs will vest on March 15, 2027, and the remaining two-thirds will vest in eight substantially equal quarterly installments after that date, as long as he continues providing service to the company on each vesting date. Following this award, he holds 1,043,056 shares of Common Stock directly.

Insider Trade Summary

Grant/Award: 120,074 shares

Grant/Award 1 txn

Insider Nygaard James P Jr

Role EVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	120,074	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,043,056 shares (Direct)

Footnotes (1)

1. F1. Represents an annual restricted stock unit ("RSU") grant. One-third of the RSUs will vest on March 15, 2027, and the remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.

Key Figures

RSU grant size: 120,074 shares Grant price: $0.00 per share Shares after transaction: 1,043,056 shares +2 more

5 metrics

RSU grant size 120,074 shares Restricted stock unit award of Common Stock to CFO

Grant price $0.00 per share Compensation-related RSU grant, not an open-market purchase

Shares after transaction 1,043,056 shares Total Common Stock directly held by CFO following grant

Initial vesting date March 15, 2027 One-third of RSUs vest on this date

Remaining vesting schedule Eight quarterly installments Two-thirds of RSUs vest in eight substantially equal quarters thereafter

Key Terms

restricted stock unit, RSU, vest, quarterly installments, +1 more

5 terms

restricted stock unit financial

"Represents an annual restricted stock unit ("RSU") grant."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU financial

"Represents an annual restricted stock unit ("RSU") grant."

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vest financial

"One-third of the RSUs will vest on March 15, 2027, and the remaining two-thirds..."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

quarterly installments financial

"remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments"

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

What insider transaction did Core Scientific (CORZ) report for James P. Nygaard Jr.?

Core Scientific’s EVP and CFO James P. Nygaard Jr. reported receiving a grant of 120,074 restricted stock units of Common Stock as equity compensation, increasing his directly held position to 1,043,056 shares after the award.

How many Core Scientific (CORZ) shares were granted to the CFO in this Form 4?

The Form 4 shows a grant of 120,074 restricted stock units of Core Scientific Common Stock to EVP and CFO James P. Nygaard Jr., recorded at a price of $0.00 per share as a compensation-related award rather than an open-market purchase.

When do the Core Scientific (CORZ) RSUs granted to the CFO vest?

One-third of the 120,074 restricted stock units will vest on March 15, 2027. The remaining two-thirds will vest in eight substantially equal quarterly installments afterward, provided he continues to provide service to Core Scientific on each vesting date.

Is the Core Scientific (CORZ) CFO’s Form 4 transaction a stock purchase or a compensation grant?

The transaction is a compensation grant, not an open-market stock purchase. The filing identifies it as a restricted stock unit award with a transaction price of $0.00 per share, classified as a grant or award acquisition of Common Stock.

What are James P. Nygaard Jr.’s Core Scientific (CORZ) holdings after this RSU grant?

After the reported RSU grant, James P. Nygaard Jr. holds 1,043,056 shares of Core Scientific Common Stock directly. This total reflects his position immediately following the 120,074-share restricted stock unit award disclosed in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nygaard James P Jr

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		120,074(1)	A	$0	1,043,056	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an annual restricted stock unit ("RSU") grant. One-third of the RSUs will vest on March 15, 2027, and the remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.

	/s/ Todd DuChene, as Attorney-in-Fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)